CGCN GROUP, LLC lobbying for ERADIVIR

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Indiana · House · Senate · $20,000.00 income · posted Jul 21, 2025

Bills named in this filing 1

HR 10545
American Relief Act, 2025

Lobbying activity 3

Budget/Appropriations

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.

Disaster Planning/Emergencies

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.

Health Issues

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.